Patent details

EP3411400 Title: TREATMENT OF INFLAMMATORY DISEASES WITH INHIBITORS OF C5A ACTIVITY

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP3411400
WO Application Number:
EP2018050146
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP18701250.5
WO Publication Number:
WO2018184739
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
Germany (DE)
Publications:

Dates

Filing date:
03/01/2018
Grant date:
22/09/2021
EP Publication Date:
12/12/2018
WO Publication Date:
11/10/2018
Claims Translations Received Date:
Claims Translation B1 Received Date:
07/10/2021
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
22/09/2021
EP B1 Publication Date:
22/09/2021
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
02/01/2038
Lapsed By Expiration Date:
Patent Validated Date:
27/10/2021
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
22/09/2021
 
 

 

Name:
InflaRx GmbH
Address:
Winzerlaer Strasse 2, 07745 Jena, Germany (DE)

Agent

Name:
dr. A. Krebs
From:
25/10/2021
Address:
HGF B.V. Benoordenhoutseweg 46, 2596 BC, Den Haag, Netherlands (NL)
To:

Inventor

1

Name:
GUO, Renfeng
Address:
Ann Arbor, MI 48103, United States of America (US)

2

Name:
RIEDEMANN, Niels C.
Address:
07749 Jena, Germany (DE)

Priority

1

Priority Patent Number:
17189938
Priority Date:
07/09/2017
Priority Country:
European Patent Office (EPO) (EP)

2

Priority Patent Number:
17177657
Priority Date:
23/06/2017
Priority Country:
European Patent Office (EPO) (EP)

3

Priority Patent Number:
17164573
Priority Date:
03/04/2017
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC or IDT classification:
C07K 16/18; A61P 17/00; A61P 17/10; A61P 29/00; A61P 37/02;

Publication

Bulletin

1

Bulletin Heading:
EP3
Journal edition number:
43/21
Publication date:
27/10/2021
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

2

Bulletin Heading:
EP2
Journal edition number:
38/21
Publication date:
22/09/2021
Description:
European patents granted for the Netherlands

European Patent Bulletin

1

Issue number:
202143
Publication date:
27/10/2021
Description:
Application number/publication number of the divisional application (Art. 76) changed

2

Issue number:
202138
Publication date:
22/09/2021
Description:
Grant (B1)

Annual Fee

Annual Fee(s) Due Date:
31/01/2026
Annual Fee Number:
9
Annual Fee Amount:
340 Euro
Last Annual Payment Date:
22/01/2025
Last Annual Fee Paid Number:
8
Last Annual Fee Paid Amount:
280 Euro
Payer:
PAVIS GmbH
Filing date Document type Document Description Number of pages File Type
26/10/2021 Outgoing Correspondence Letter no formal defects 1 PDF /3/8/4/6/2/0800726483/docs/ep18701250.5_1_442364l271.pdf
07/10/2021 Claims First filed claims 1 PDF /3/8/4/6/2/0800726483/docs/ep18701250.5_0_claims20211007104525546.pdf